Icomb 10 Mg/5 Mg Capsule Rigide

Ramipril, the active ingredient in Icomb 10 Mg/5 Mg Capsule Rigide, is an ACE inhibitor presented as a 10 mg/5 mg rigid capsule for oral use. Together with amlodipine besilate, it provides antihypertensive therapy for adults with essential hypertension, helping to lower systolic and diastolic blood pressure.

GNH USA supplies Icomb 10 Mg/5 Mg Capsule Rigide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, ensuring consistent quality and regulatory compliance across global markets.

Icomb 10 Mg/5 Mg Capsule Rigide is indicated for conditions within the hypertension disease family, where it helps control elevated blood pressure.

- Essential hypertension: reduces systolic and diastolic pressure to target levels. - Primary hypertension: provides combined ACE inhibition and calcium‑channel blockade for better blood pressure control. - Hypertension in patients requiring dual therapy: offers convenient single‑pill regimen to improve adherence.

Like all antihypertensive agents, Icomb 10 Mg/5 Mg Capsule Rigide may cause adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness: especially after standing. - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Flushing: sensation of warmth, often on the face.

Serious or Rare Side Effects: - Angioedema: rapid swelling of lips, tongue or airway, requiring emergency care. - Severe hypotension: marked drop in blood pressure leading to fainting. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing Icomb 10 Mg/5 Mg Capsule Rigide, clinicians should consider the following precautions.

- Renal impairment: monitor kidney function and adjust dose if necessary. - Hyperkalemia risk: avoid concomitant potassium‑sparing diuretics or supplements. - Pregnancy: avoid use because safety in pregnancy is not established. - Elderly patients: start at lower dose and monitor for orthostatic hypotension. - Store at below 25°C: keep in the original container, protect from moisture and light.

Icomb 10 Mg/5 Mg Capsule Rigide can interact with several medicines; awareness of major and moderate interactions helps prevent therapeutic failure or toxicity.

Major Interactions (Avoid): - Aliskiren in patients with diabetes: combined renin‑angiotensin blockade may cause renal impairment. - Potassium supplements or potassium‑sparing diuretics: increase risk of hyperkalemia. - NSAIDs (e.g., ibuprofen, naproxen): may blunt antihypertensive effect and affect kidney function.

Moderate Interactions (Monitor Closely): - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): raise amlodipine levels, may cause edema or hypotension. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): lower amlodipine concentrations, reducing efficacy. - Loop or thiazide diuretics: additive blood‑pressure lowering, monitor for excessive hypotension.